Bank Of America Corp Cellectar Biosciences, Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$3.5 - $6.9 $5,250 - $10,350	1,500 New	1,500 $6,000
Q1 2022 May 16, 2022	SELL	$4.6 - $7.8 $487 - $826	-106 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$6.1 - $10.2 $646 - $1,081	106 New	106 $0
Q3 2021 Nov 15, 2021	SELL	$8.2 - $12.4 $180 - $272	-22 Closed	0 $0
Q2 2021 Sep 13, 2021	BUY	$11.8 - $18.2 $259 - $400	22 New	22 $0

Ticker CLRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,114,290
Market Cap $13M
Description
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.